SAN DIEGO, March 15, 2022 /PRNewswire/ -- Molecular Assemblies, Inc., today announced that it has raised a $25.8 million Series B financing with participation from new investor, Casdin Capital ...

Molecular Assemblies’ enzymatic approach is based on the way that nature makes DNA—in water—to overcome the length, purity, and accuracy limitations of the chemical DNA synthesis method.

--Codexis, Inc., a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced ...

Molecular Assemblies ships out DNA orders to its first customers. Molecular Assemblies. DNA, the language of biology, is driving all synthetic biology applications, from animal-free meat to life ...

SAN DIEGO, April 15, 2021 /PRNewswire/ -- Molecular Assemblies, Inc., today announced that it has closed an oversubscribed $24 million Series A financing with significant investment from Agilent ...

Molecular Assemblies' Fully Enzymatic Synthesis (FES) is the foundation of their approach to create long, high quality, sequence specific DNA composed of 400+ base pairs.

Molecular Assemblies has pioneered Fully Enzymatic Synthesis™ (or FES™) technology with an in-process purification step to overcome the length, purity, and accuracy limitations of the current ...

REDWOOD CITY, Calif. and SAN DIEGO, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, and Molecular ...